Journal of Clinical and Experimental Pharmacology and Physiology

Introduction

Journal of Experimental Pharmacology and Clinical Trials is an internationally recognized, peer-reviewed journal committed to the advancement of knowledge in the fields of pharmacology and physiology. Our journal serves as a dynamic platform for the dissemination of high-quality research that bridges experimental findings with clinical applications, providing insights that have the potential to transform healthcare practices worldwide. By promoting the publication of original research, comprehensive reviews, case reports, and short communications, The Journal of Experimental Pharmacology and Clinical Trials aims to foster scientific dialogue among researchers, clinicians, educators, and policymakers, enhancing the global understanding of drug actions, therapeutic strategies, and clinical research advancements.

At Journal of Experimental Pharmacology and Clinical Trials, we prioritize studies that explore the complex interactions between pharmacological agents and biological systems. Our journal is dedicated to advancing research in areas such as drug discovery, molecular pharmacology, clinical therapeutics, neurophysiology, cardiovascular physiology, endocrine research, immunopharmacology, toxicology, regenerative medicine, and translational research. We encourage contributions that not only present experimental results but also provide meaningful interpretations that can guide clinical practice and future research directions.

Aims & Scope

Journal of Experimental Pharmacology and Clinical Trials aims to foster the exchange of scientific knowledge across the fields of pharmacology and physiology, encouraging studies that explore drug actions, pharmacokinetics, pharmacodynamics, molecular mechanisms, and clinical efficacy. The journal also prioritizes research on disease pathophysiology, experimental therapeutics, biomarkers, and physiological responses to interventions. By integrating both clinical and experimental perspectives, we aim to provide a holistic understanding of how pharmacological agents interact with biological systems and influence disease outcomes. We welcome original research articles, systematic reviews, meta-analyses, case studies, and short communications that adhere to rigorous scientific standards. Our scope extends to investigations involving molecular pharmacology, neurophysiology, cardiovascular physiology, endocrine research, immunopharmacology, toxicology, and regenerative medicine. Through this multidisciplinary approach, Journal of Experimental Pharmacology and Clinical Trials strives to serve as a trusted source of knowledge for researchers, educators, healthcare professionals, and policymakers who seek to advance therapeutic innovations and evidence-based clinical practices.